TOR-BSST© eLearning Training for Stroke

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University Health Network, Toronto, Canada
Stroke+2 More
TOR-BSST© eLearning Training - Other
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

Stroke is a leading cause of death and disability globally. Dysphagia, swallowing difficulty, is common following stroke, affecting about 55% of all stroke patients. People with stroke and dysphagia are three times more likely to develop pneumonia compared to patients with no dysphagia. Stroke best practice guidelines recommend early identification of dysphagia by bedside testing (called screening) of all patients admitted to hospital with stroke. Our group was the first to develop a screening tool for stroke patients, the Toronto Bedside Swallowing Screening Test (TOR-BSST©). It uses a step-by-step process to identify patients with dysphagia risk. TOR-BSST© screeners are health professionals who have successfully completed a live 4-hr training provided by a Speech Language Pathologist (SLP). There is good evidence that this training increases the accuracy of screening. However, a 4-hr live session is not acceptable with limited healthcare resources. Our aim is to evaluate the accuracy of an innovative eLearning program to train TOR-BSST© screeners. If successful, this project will shorten training time, reduce hospital resource burden, and ensure a sustainable dysphagia screening program for people with stroke in all hospitals.

Eligible Conditions

  • Stroke
  • Dysphagia

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 1 Secondary · Reporting Duration: 30 minutes

30 minutes
Online Assessment of Trained Screeners (Module 3)
Online Test of Screener Accuracy (Module 4)

Trial Safety

Trial Design

3 Treatment Groups

1
1 of 3
2
1 of 3
3
1 of 3
Active Control
Experimental Treatment

351 Total Participants · 3 Treatment Groups

Primary Treatment: TOR-BSST© eLearning Training · No Placebo Group · N/A

2
Other
Experimental Group · 1 Intervention: TOR-BSST© eLearning Training · Intervention Types: Other
3
Other
Experimental Group · 1 Intervention: TOR-BSST© eLearning Training · Intervention Types: Other
1
Other
ActiveComparator Group · 1 Intervention: Standard TOR-BSST© Training · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 30 minutes

Trial Background

Rosemary Martino, PhD
Principal Investigator
University Health Network, Toronto
Closest Location: University Health Network · Toronto, Canada
Photo of Toronto  1Photo of Toronto  2Photo of Toronto  3
2005First Recorded Clinical Trial
7 TrialsResearching Stroke
273 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.